Skip to main content
. 2019 Sep 4;317(5):G716–G726. doi: 10.1152/ajpgi.00115.2019

Table 2.

Most significantly affected proteins in diabetic and idiopathic gastroparesis

Proteins Fold Change Adjusted P Value
Diabetic gastroparesis vs. controls (n = 9 and 5)
    Trefoil factor 2 −11.3 1.1 × 10−10
    FABP3, heart −2.8 1.9 × 10−5
    GPD1 −12.2 7.8 × 10−5
    PRSS1 −2.3 1.8 × 10−4
    IL-1R2 −1.5 1.7 × 10−3
    CSF3 −1.3 2.4 × 10−3
    CA3 −8.3 2.8 × 10−3
    AHSG −1.2 6.1 × 10−3
    CA1 −4.7 6.7 × 10−3
    CAMK2B 1.7 7.2 × 10−3
Idiopathic gastroparesis vs. controls (n = 7 and 5)
    TFF2 −11.3 2.7 × 10−10
    SLIRK5 2.0 2.6 × 10−4
    PGD 1.5 3.3 × 10−4
    FABP3, heart −2.4 3.7 × 10−4
    GPD1 −9.2 4.4 × 10−4
    NRG1 1.2 4.4 × 10−4
    FGF12 1.3 5.7 × 10−4
    CSF3 −1.4 6.4 × 10−4
    AIP 1.5 6.9 × 10−4
    FGF1 1.9 6.9 × 10−4

AHSG, α-2-HS-glycoprotein; AIP, AH receptor-interacting protein; CA1, carbonic anhydrase 1; CA3, carbonic anhydrase 3; CAMK2B, calcium/calmodulin-dependent protein kinase type II subunit-β; CSF3, granulocyte colony-stimulating factor; FABP3, fatty acid-binding protein; FGF1 and -12, fibroblast growth factor 1 and 12, respectively; GPD1, glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic; IL-1R2, interleukin-1 receptor type 2; NRG1, neuregulin-1; PGD, 6-phosphogluconate dehydrogenase, decarboxylating; PRSS1, trypsin-1; SLIRK5, SLIT and NTRK-like protein 5; TFF2, trefoil factor 2.